Panacea Index Logo

Command Palette

Search for a command to run...

Reflections About Inflammatory Bowel Disease and Vitamins A and D.

Journal of medicinal food
December 1, 2016
Sandra Maria Barbalho et al. (7 authors)
Journal ArticleReviewHuman Study
Study Details

Study Goal

The researchers aimed to review current evidence linking Vitamin A and Vitamin D with inflammatory bowel diseases (IBDs), focusing on their potential roles in reducing inflammation.

Results Summary

The study suggests that Vitamin A, particularly its active form retinoic acid, may be involved in immune regulation and inflammation resolution through mechanisms like growth factor-β and interleukin-10 (IL-10) release. Deficiency in Vitamin A is associated with increased disease activity in IBDs.

Population

Patients with inflammatory bowel diseases (ulcerative colitis and Crohn's disease).

Effective Dosage

Not specified

Duration

Not specified

Interactions

None mentioned

Extracted Claims (5)
InterventionDirectionEndpointPopulationDosageImpactClaim #
Vitamin A (VA)
decrease
inflammation
patients with ulcerative colitis and Crohn's disease
-
may be associated with reduction
#1
Vitamin D (VD)
decrease
inflammation
patients with ulcerative colitis and Crohn's disease
-
may be associated with reduction
#2
retinoic acid (active form of VA)
increase
growth factor-β and release of interleukin-10 (IL-10)
-
-
may be related to
#3
retinoic acid (active form of VA)
decrease
resolution of the inflammation
-
-
involved with
#4
Vitamin A deficiency
increase
disease activity
-
-
associated with the increase
#5
Abstract

Ulcerative colitis and Crohn's disease are two major forms of the inflammatory bowel diseases (IBDs). Vitamin A (VA) and vitamin D (VD) may be associated with reduction in inflammation in these disorders. The aim of this review was to show the current evidence that may associate VA and VD with IBDs. Data linking VA, VD, and IBDs were studied. Both VA and VD may be related to the immune system in different manners. The active form of VA, retinoic acid, may be related to the growth factor-β and release of interleukin-10 (IL-10), thus involved with the resolution of the inflammation. Its deficiency is associated with the increase of disease activity. The active form of VD is 1,25(OH)

Medical Subject Headings (MeSH)
Antimicrobial Cationic PeptidesColitis, UlcerativeCrohn DiseaseCytokinesDefensinsHomeostasisHumansImmune SystemInflammationInflammatory Bowel DiseasesInterleukin-10InterleukinsReceptors, CalcitriolTumor Necrosis Factor-alphaVitamin AVitamin DCathelicidins
Study Links
Quality Scores
SafetyNot Assessed
Efficacy70/10
Quality60/10
Citation Metrics
Total Citations15
Citations/Year1.7
Relative Citation Ratio0.72
NIH Percentile38.3%
Research Impact Scores
APT Score0.50
Weight Score1.54
Normalized Score0.60
Related Supplements